BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Savara 

3925 West Braker Lane

Austin  Texas  78759  U.S.A.
Phone: 512-961-1891 Fax: 512-305-0009


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Savara Reels In $10 Million 10/6/2014 6:12:41 AM
Savara Announces FDA Grant of Qualified Infectious Disease Product (QIDP) And Fast Track Designation For Its Lead Product, AeroVanc 12/10/2013 11:25:05 AM
Savara Appoints Two New Members To Its Board of Directors 12/5/2013 6:27:07 AM
Cystic Fibrosis Foundation Therapeutics, Inc. Provides Savara $1.7 Million Award for Development of AeroVanc for MRSA Lung Infection in Cystic Fibrosis Patients 10/17/2013 10:47:30 AM
Savara Updates Series B Funding Tranche to $14.3 Million 6/26/2013 8:43:46 AM
Success With an Angel Syndicate: How One Pharma Startup, Savara, Raised $16 Million Without VCs 6/18/2013 7:40:31 AM
Savara Initiates Phase 2 Clinical Trial of AeroVanc for MRSA Lung Infection in Cystic Fibrosis Patients 4/18/2013 9:52:46 AM
Savara Lands $7.4 Million to Close a $16 Million Series B Round 3/21/2013 8:33:58 AM
Savara Announces Formation of Clinical Advisory Board 2/26/2013 9:40:37 AM
Savara' AeroVanc Granted U.S. Orphan Drug Designation for the Treatment of MRSA Lung Infection in Cystic Fibrosis Patients 11/13/2012 10:19:15 AM
12